Developer of next-generation bio-molecules intended for the treatment of cancer and fibrosis. The company's bio-molecules include novel therapeutics that modulate key components of immunosuppression i...

Healthcare
Genève, Switzerland
Founded 2017
33 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$159.7M
Last Round
N/A

Get the full picture

Create a free account to unlock iOnctura's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required